Waters D D, Chaitman B R, Szlachcic J, Théroux P
Arch Mal Coeur Vaiss. 1983 Feb;76 Spec No:161-8.
A subgroup of 22 patients with Prinzmetal angina and a good clinical response to treatment with calcium inhibitors was studied to determine whether the ergonovine provocation test could help decide when to stop treatment. Before treatment, all patients had ST elevation during the ergonovine test which was performed in the coronary care unit. After 9,4 +/- 4,7 months' treatment, all 22 patients were asymptomatic. Their treatment was discontinued and the ergonovine test repeated. Twelve of the 22 patients had no anginal pain or ST segment changes during the test. Without therapy, none of these 12 patients have experienced recurrence of angina during a follow up period of 4,2 +/- 2,9 months. Angina with ST elevation occurred in 7 patients during the ergonovine test, as observed during their initial provocation tests. In 3 other patients, ergonovine induced ST depression in the leads in which ST elevation had been recorded during their initial tests. Treatment was restarted in these 10 patients with positive tests. There were no complications. Spontaneous remissions of symptoms and negative ergonovine tests may be observed in some patients with Prinzmetal angina. Without treatment this group of patients may remain asymptomatic for several months.
对22例患有变异型心绞痛且对钙拮抗剂治疗有良好临床反应的患者进行了研究,以确定麦角新碱激发试验是否有助于决定何时停止治疗。治疗前,所有患者在冠心病监护病房进行麦角新碱试验时均出现ST段抬高。经过9.4±4.7个月的治疗后,所有22例患者均无症状。他们停止治疗并重复进行麦角新碱试验。22例患者中有12例在试验期间无心绞痛或ST段改变。在4.2±2.9个月的随访期内,这12例患者无一例在未接受治疗的情况下出现心绞痛复发。在麦角新碱试验期间,7例患者出现ST段抬高型心绞痛,如同他们最初激发试验时所观察到的那样。在另外3例患者中,麦角新碱在其最初试验时记录到ST段抬高的导联中诱发了ST段压低。对这10例试验阳性的患者重新开始治疗。未出现并发症。在一些变异型心绞痛患者中可观察到症状的自发缓解和麦角新碱试验阴性。未经治疗,这群患者可能数月无症状。